🇺🇸 FDA
Patent

US 7361332

Treating tumors using implants comprising combinations of allogeneic cells

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 7361332 (Treating tumors using implants comprising combinations of allogeneic cells) held by The Regents of the University of California expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2239/50